Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Asthma Drug Helps Desensitize Multiple Food Allergies

Kari Nadeau (Stanford University)

28 February 2014. Medical researchers at Stanford University in California and Johns Hopkins University in Baltimore found in an early-stage clinical trial that an asthma drug dramatically reduces the time needed for patients to lower their sensitivity to several food allergies at one time. The team led by Stanford’s Kari . . . → Read More: Asthma Drug Helps Desensitize Multiple Food Allergies

Life Sciences Investment Company Closes New Fund

(M4D Group/Flickr)

28 February 2014. Abingworth LLP, an investment company based in London, closed its 10th fund designed for financing life sciences and health care enterprises. The company says its Abingworth Bioventures VI fund raised £225 million ($375 million), exceeding its target of £200 million.

Abingworth expects its Bioventures VI fund to invest in . . . → Read More: Life Sciences Investment Company Closes New Fund

Mobile Low-Power Gesture-Recognition System Developed

AllSee prototype attached to smartphone (University of Washington)

27 February 2014. Computer scientists and engineers at University of Washington in Seattle developed an inexpensive gesture recognition system for mobile devices that consumes minimal power, with potential applications in robotics and “Internet-of-things” computing. The team led by Shyam Gollakota, director of the university’s Networks and . . . → Read More: Mobile Low-Power Gesture-Recognition System Developed

Clinical Trial Testing New, Current Breast Cancer Drugs

(National Cancer Institute)

27 February 2014. The global pharmaceutical company Eisai Inc. is starting a late-stage clinical trial of its drug eribulin mesylate to treat certain types of recurring or metastatic breast cancer, compared to the current chemotherapy drug paclitaxel. The trial is a joint project of Eisai’s U.S. subsidiary, in Woodcliff Lakes, New . . . → Read More: Clinical Trial Testing New, Current Breast Cancer Drugs

Zoetis Funding Cat Health Foundation Research Awards

(fnal.gov)

26 February 2014. Zoetis Inc., an animal health company in Florham Park, New Jersey, is funding grants to researchers for studies into pain, joint health, and kidney disorders in cats. Grants totaling $100,000 will be made available through the Winn Feline Foundation, with a due date for proposals of 21 April 2014.

The . . . → Read More: Zoetis Funding Cat Health Foundation Research Awards

Walgreens, UCSF Partner on Patient Medication Management

(Phillip Pessar/Flickr)

26 February 2014. The Walgreens pharmacy chain and University of California in San Francisco are collaborating on new pharmacy services that help patients manage medications to improve their overall health. The company and university are testing this new retail model in a Walgreens store located near the UCSF campus, but financial aspects . . . → Read More: Walgreens, UCSF Partner on Patient Medication Management

Implanted Heart Membrane Device Created by 3-D Printer

Igor Efimov (Washington University, St. Louis)

25 February 2014. Engineers and medical researchers at Washington University in St. Louis and University of Illinois in Champaign used a three-dimensional printer to create a membrane that fits over the heart, with electronic components to monitor its functions. The team led by Washington University’s Igor Efimov and . . . → Read More: Implanted Heart Membrane Device Created by 3-D Printer

Paper Test Strips Devised to Diagnose Cancer, Blood Clots

Sangeeta Bhatia (Bryce Vickmark, Massachusetts Institute of Technology)

25 February 2014. Biomedical engineers at Massachusetts Institute of Technology developed and tested with lab mice a simple, inexpensive paper test strip system to diagnose non-communicable diseases. The team led by medical engineering professor Sangeeta Bhatia published its findings online yesterday in the journal Proceedings of . . . → Read More: Paper Test Strips Devised to Diagnose Cancer, Blood Clots

Gene Modified Potatoes Developed with Blight Resistance

Jonathan Jones (The Sainsbury Laboratory)

24 February 2014. Researchers at The Sainsbury Laboratory in Norwich, U.K. developed and field tested a new type of potato with greater genetically modified resistance to late blight, a long-time scourge of potato growers. The team led by Sainsbury plant biologist Jonathan Jones reported its findings online last week . . . → Read More: Gene Modified Potatoes Developed with Blight Resistance

Natural Regenerative Cellular Matrix Frame Grown in Lab

Aligned fibroblast nanofibers (Michigan Technological Universtiy)

24 February 2014. Biomedical engineers at Michigan Technological University in Houghton and Duke University in Durham, North Carolina developed a process for creating a framework needed to turn stem cells into engineered regenerative tissue. The research team led by Michigan Tech professor Feng Zhao published its findings online . . . → Read More: Natural Regenerative Cellular Matrix Frame Grown in Lab